McCarthy Sean A. 4
4 · CytomX Therapeutics, Inc. · Filed Nov 10, 2025
Insider Transaction Report
Form 4
McCarthy Sean A.
DirectorCEO
Transactions
- Sale
Class A Common Stock
2025-11-06$4.54/sh−101,793$461,906→ 987,891 total
Holdings
- 93,158(indirect: See footnote)
Class A Common Stock
Footnotes (4)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on August 27, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $4.50 to $4.62, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]Includes 488,750 restricted stock units.
- [F4]Shares held by Sean A. McCarthy 2018 Trust, of which the Reporting Person is trustee.